BlackRock’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.3M Buy
3,642,347
+68,978
+2% +$574K ﹤0.01% 3018
2025
Q4
$29.7M Buy
3,573,369
+155,373
+5% +$1.67M ﹤0.01% 2852
2025
Q3
$49.8M Buy
3,417,996
+367,800
+12% +$4.4M ﹤0.01% 2497
2025
Q2
$34.3M Buy
3,050,196
+1,808,161
+146% +$14M ﹤0.01% 2695
2025
Q1
$7.08M Sell
1,242,035
-46,563
-4% -$474K ﹤0.01% 3487
2024
Q4
$12.7M Buy
1,288,598
+202,211
+19% +$1.73M ﹤0.01% 3299
2024
Q3
$8.85M Buy
1,086,387
+36,116
+3% +$362K ﹤0.01% 3468
2024
Q2
$14M Sell
1,050,271
-771,281
-42% -$23M ﹤0.01% 3187
2024
Q1
$84.5M Buy
1,821,552
+1,680
+0.1% +$87K ﹤0.01% 2151
2023
Q4
$123M Buy
1,819,872
+2,390
+0.1% +$146K ﹤0.01% 1959
2023
Q3
$132M Buy
1,817,482
+112,411
+7% +$8.99M ﹤0.01% 1829
2023
Q2
$127M Buy
1,705,071
+438,469
+35% +$26M ﹤0.01% 1885
2023
Q1
$67.4M Buy
1,266,602
+90,203
+8% +$5.72M ﹤0.01% 2266
2022
Q4
$79.5M Buy
1,176,399
+399,079
+51% +$36.7M ﹤0.01% 2161
2022
Q3
$97M Sell
777,320
-31,512
-4% -$3.76M ﹤0.01% 1987
2022
Q2
$77M Buy
808,832
+410,000
+103% +$50M ﹤0.01% 2199
2022
Q1
$64.3M Sell
398,832
-10,071
-2% -$1.96M ﹤0.01% 2429
2021
Q4
$136M Buy
+408,903
New +$194M ﹤0.01% 2002

Other funds holding DNA